Tolerizing Strategies for the Treatment of Autoimmune Diseases: From ex vivo to in vivo Strategies

A Cauwels, J Tavernier - Frontiers in immunology, 2020 - frontiersin.org
Autoimmune diseases such as multiple sclerosis (MS), type I diabetes (T1D), inflammatory
bowel diseases (IBD), and rheumatoid arthritis (RA) are chronic, incurable, incapacitating …

The dichotomic role of single cytokines: Fine-tuning immune responses

RCMC Silva, LH Travassos, FF Dutra - Cytokine, 2024 - Elsevier
Cytokines are known for their pleiotropic effects. They can be classified by their function as
pro-inflammatory, such as tumor necrosis factor (TNF), interleukin (IL) 1 and IL-12, or anti …

Bacteria and bacteriophage consortia are associated with protective intestinal metabolites in patients receiving stem cell transplantation

E Thiele Orberg, E Meedt, A Hiergeist, J Xue… - Nature Cancer, 2024 - nature.com
The microbiome is a predictor of clinical outcome in patients receiving allogeneic
hematopoietic stem cell transplantation (allo-SCT). Microbiota-derived metabolites can …

STING differentially regulates experimental GVHD mediated by CD8 versus CD4 T cell subsets

CS Bader, H Barreras, CO Lightbourn… - Science translational …, 2020 - science.org
The stimulator of interferon genes (STING) pathway has been proposed as a key regulator of
gastrointestinal homeostasis and inflammatory responses. Although STING reportedly …

The intestinal microbiota and cellular therapy: implications for impact and mechanisms

J Xie, M Smith - Blood, 2024 - ashpublications.org
The microbiota, comprising bacteria, fungi, and viruses residing within our bodies, functions
as a key modulator in host health and states, including immune responses. Studies have …

CD11c participates in triggering acute graft‐versus‐host disease during bone marrow transplantation

Q Wang, X Su, Y He, M Wang, D Yang, R Zhang… - …, 2021 - Wiley Online Library
CD11c is a canonical dendritic cell (DC) marker with poorly defined functions in the immune
system. Here, we found that blocking CD11c on human peripheral blood mononuclear cell …

Innovations in treating acute graft-versus-host disease: a review of preclinical targets and strategies

H Duan, Y Ru, J Chen - Expert Opinion on Therapeutic Targets, 2024 - Taylor & Francis
Introduction Acute graft-versus-host disease (aGVHD) is a major complication of post-
allogeneic hematopoietic stem cell transplantation (allo-HSCT) that severely impacts patient …

Broad virus detection and variant discovery in fecal samples of hematopoietic transplant recipients using targeted sequence capture metagenomics

SA Jansen, W Nijhuis, HL Leavis… - Frontiers in …, 2020 - frontiersin.org
Pediatric allogeneic hematopoietic stem cell transplantation (HSCT) patients often suffer
from gastro-intestinal (GI) disease caused by viruses, Graft-versus-Host Disease (GVHD) or …

Interfering With Inflammation: Heterogeneous Effects of Interferons in Graft-Versus-Host Disease of the Gastrointestinal Tract and Inflammatory Bowel Disease

E Haring, R Zeiser, P Apostolova - Frontiers in Immunology, 2021 - frontiersin.org
The intestine can be the target of several immunologically mediated diseases, including
graft-versus-host disease (GVHD) and inflammatory bowel disease (IBD). GVHD is a life …

Old Dog, New Trick: Type I IFN–Based Treatment for Acute Myeloid Leukemia

A Alsufyani, R Alanazi, JF Woolley, LN Dahal - Molecular Cancer Research, 2021 - AACR
Despite strong biological rationale for the use of type-I IFNs for the treatment of acute
myeloid leukemia (AML), their usage is limited to few hematologic malignancies. Here, we …